Richieri-Costa–Colletto Syndrome

Richieri-Costa–Colletto syndrome.” In current medical references this name is used as a synonym for Acro-fronto-facio-nasal dysostosis (AFFND)—an extremely rare, autosomal-recessive cranio-skeletal condition first described by Richieri-Costa and colleagues in the 1980s. Key signs include short stature; wide-set eyes; a broad, notched nasal tip; cleft lip and/or palate; and limb anomalies such as post-axial campto-brachy-poly-syndactyly, fibular hypoplasia, and abnormal foot structure. AFFND is listed in Orphanet with “Richieri-Costa-Colletto syndrome” as a synonym, and the Disease Ontology gives the same core feature set. Affected families are rare, and inheritance is autosomal recessive, so both parents usually carry one silent gene change. Orphadisease-ontology.org

Richieri-Costa–Colletto syndrome (AFFND) is a very rare condition present at birth. It mainly affects the face, front of the skull, nose, hands, feet, and overall growth. Children are usually shorter than peers. The eyes are set wider apart. The nose tip looks broad and split. A cleft lip and/or cleft palate may be present, which can cause feeding and speech problems. The hands and feet may have extra, short, bent, joined, or missing fingers or toes. The fibula bone in the lower leg can be under-developed, so ankles and feet may need support or surgery. Learning problems can occur. Most children need long-term care from a team of specialists. Orphadisease-ontology.org

Richieri-Costa–Colletto syndrome is an ultra-rare genetic condition that affects the way the face and the bones of the limbs form before birth. Children are usually short in height, and they often have a wide spacing between the eyes, a broad notched tip of the nose, and a cleft lip and/or cleft palate. The hands and feet may show extra or fused fingers or toes, short fingers, bent fingers, missing or under-developed bones (for example the fibula in the lower leg), and unusual shapes of the feet. Most children have learning difficulties of varying degrees. Doctors first described this pattern of features in Brazilian families, and later reports from other countries confirmed that it is a distinct disorder. The condition is usually inherited in an autosomal recessive way (both copies of a gene need to be changed). Orpha+1

Other names you might see

• Acro-fronto-facio-nasal dysostosis (AFFND) — the main medical name used today. Orpha

• Richieri-Costa–Colletto syndrome — an older eponym recognizing two of the first authors who described the disorder. Orpha

• Acrofrontofacionasal dysostosis type 1 (AFFND1) — a genetic subtype label. PubMed

• Acrofrontofacionasal dysostosis type 2 (AFFND2) — a related, even rarer form that especially adds genitourinary differences. MalaCards

⚠️ This syndrome is not the same as Richieri-Costa–Pereira syndrome (RCPS), which is another acrofacial dysostosis caused by changes in a different gene (EIF4A3) and characterized by a median mandibular cleft and other features. The names are similar because several of the same clinicians helped describe both conditions, but they are distinct disorders. OrphaPubMed

---

Types

1) Acrofrontofacionasal dysostosis type 1 (AFFND1)

This is the “classic” form first described in Brazilian families and later in other populations. It is autosomal recessive. Recent genetic work shows that some families carry biallelic variants in the NBAS gene; NBAS helps with cell processes such as moving proteins between the Golgi and ER and with quality-control of RNA. In other AFFND1 families, researchers identified a recessive intronic variant in PIGB, a gene needed to build GPI anchors that help many proteins attach to cell membranes. These discoveries explain why bones and facial structures may not form normally. PubMed+1GeneCardsPMC

2) Acrofrontofacionasal dysostosis type 2 (AFFND2; Naguib–Richieri-Costa syndrome)

This extremely rare form combines the facial/limb pattern with genitourinary anomalies (for example hypospadias in boys). It also appears to be autosomal recessive. A single responsible gene has not been firmly established yet. MalaCards

---

Causes

In a genetic syndrome like this, “causes” are best understood as the underlying genetic changes and the biological pathways they disturb. Some items below describe specific genes; others explain the key developmental processes those genes control.

1. Biallelic NBAS variants (loss-of-function) — When both copies of NBAS are altered, cells cannot move proteins properly between the Golgi and the endoplasmic reticulum and may also have problems with RNA quality control. This can disrupt growth of facial prominences and limb buds, leading to the AFFND1 pattern. PubMedGeneCards

2. Biallelic PIGB variants — PIGB is needed to synthesize GPI anchors. Without normal GPI anchors, many cell-surface proteins cannot reach their proper location, disturbing signals that guide craniofacial and limb development. PubMed

3. Autosomal-recessive inheritance — The risk rises when both parents silently carry one changed copy; the child who inherits both will show the condition. Orpha

4. Consanguinity (parents related by blood) — increases the chance that both parents carry the same rare recessive variant, making an affected child more likely. (General genetics principle, also reflected in early familial reports.) PubMed

5. Disrupted frontonasal process signaling — Signals that pattern the forehead, nose, and midface must be precisely timed; disturbed pathways (downstream of NBAS/PIGB effects on cellular trafficking and membrane proteins) can cause the typical facial features. (Frontonasal malformation biology overview.) PMC

6. Altered protein trafficking (Golgi-to-ER) — Core NBAS function; disturbance affects secretion of factors required for bone and cartilage models in the face and limbs. GeneCards

7. Impaired nonsense-mediated mRNA decay (NMD) — NBAS participates in RNA surveillance; faulty NMD can change key developmental protein levels. PMC

8. Defective GPI-anchor biosynthesis — Core PIGB function; many morphogen receptors are GPI-anchored, so signaling gradients that sculpt the embryo are weakened or misdirected. GeneCards

9. Disrupted limb patterning cues — Limb buds rely on gradients like SHH/FGF; trafficking and membrane-anchoring defects can blunt these cues, producing extra/fused/short digits. (Mechanistic inference anchored in NBAS/PIGB biology and limb patterning principles.) GeneCards+1

10. Early cartilage template abnormalities (endochondral ossification) — If signaling to cartilage cells is faulty, bones that normally form from cartilage (like long bones and some facial bones) may be short or misshapen. (Pathway rationale consistent with dysostosis definitions.) Orpha

11. Clefting due to failed palatal shelf elevation/fusion — Craniofacial signal disruption can prevent the two palatal shelves from lifting and joining, creating cleft palate. (Frontonasal development review.) PMC

12. Abnormal neural crest cell migration — Many facial bones derive from neural crest; disturbed trafficking/anchoring can impair their migration and survival. (Developmental biology context.) PMC

13. Failure of normal fibula development — The fibula (often hypoplastic) requires precise distal limb signaling; pathway disturbance explains the recurrent lower-leg findings. MalaCards

14. Disturbed digital separation (apoptosis) — Inadequate interdigital remodeling can yield syndactyly/polysyndactyly. (Mechanistic principle aligned with clinical phenotype.) MalaCards

15. Secondary effects on growth hormone/IGF signaling — Children are often short; chronic cellular stress and mis-trafficking can secondarily affect growth pathways. (Physiologic inference tied to short stature reports.) MalaCards

16. Genetic heterogeneity — More than one gene can cause the same clinical picture (e.g., NBAS and PIGB), which is common in rare dysostoses. PubMed

17. Population founder effects in small communities — When a variant arises in a small population, it can become more frequent by chance, raising local risk. (General rare-disease principle; early Brazilian kindreds illustrate this.) PubMed

18. Modifier genes — Other variants can worsen or soften the phenotype by altering shared pathways (e.g., GPI-anchor cargo proteins), helping explain variability between families. (Genetic-architecture principle applied to AFFND.) PubMed

19. Epigenetic influences — Even with the same variant, differences in gene regulation during embryogenesis can shift severity. (General developmental genetics insight.) PMC

20. Environmental cofactors during organogenesis — While not a primary cause, maternal illness, severe nutritional deficiency, or teratogens could add to severity when the embryo already has a high-risk genotype. (Conservative developmental medicine context.) PMC

---

Common symptoms and signs

1. Wide-spaced eyes (hypertelorism) — The eye sockets form slightly farther apart than usual, giving a characteristic facial look. MalaCards

2. Broad, notched nasal tip — The lower nose cartilages are wide and sometimes split, producing the hallmark nasal shape. MalaCards

3. Cleft lip and/or cleft palate — Openings in the upper lip and/or the roof of the mouth can affect feeding, speech, and ear health and usually need surgery. MalaCards

4. Short stature — Children grow more slowly than average and remain shorter as adults. MalaCards

5. Intellectual disability or global developmental delay — Learning and developmental support are often needed; the degree varies. MalaCards

6. Postaxial camptobrachy-polysyndactyly — Fingers may be short, bent, fused, or extra, especially on the ulnar (postaxial) side of the hand. MalaCards

7. Foot anomalies — Toes may be extra or fused; feet can be unusually shaped, sometimes with clubfoot that affects walking if untreated. MalaCards

8. Fibular hypoplasia — The outer lower-leg bone may be small or partly absent, which can shorten the limb or change ankle alignment. MalaCards

9. Eye anomalies — Some children have structural eye differences; regular eye checks are important. MalaCards

10. Ear differences — External ear shape may be unusual; hearing loss is possible and should be screened. Orpha

11. Dental and jaw issues — Clefting and midface changes can crowd teeth and alter bite; dental/orthodontic care is routine. Orpha

12. Speech and feeding difficulties — Cleft palate and facial tone differences can cause nasal speech and early feeding problems, improved by therapy and surgery. Orpha

13. Urogenital anomalies (especially in AFFND2) — Examples include hypospadias in boys and other genitourinary differences. MalaCards

14. Behavioral challenges — Some children show attention, learning, or adaptive behavior difficulties and benefit from early special education. MalaCards

15. General facial gestalt — The combination of forehead, nasal, and midface features gives clinicians a recognizable pattern that points toward the diagnosis. Orpha

---

Diagnostic tests

A) Physical examination

1. Detailed craniofacial exam — A genetics/craniofacial team looks for the typical pattern (wide eye spacing, broad notched nose, clefting, ear shape). This bedside exam guides which tests to order next. Orpha

2. Anthropometric measurements — Head, face, and limb measurements are compared with age-matched charts; unusual ratios support a craniofacial dysostosis. Orpha

3. Hand and foot inspection — Counting fingers/toes, checking for fusions or extra digits, and assessing flexibility helps document the limb pattern. MalaCards

4. Spine and lower-limb alignment exam — Looks for bowed legs, leg-length differences, and ankle/foot alignment problems linked to fibular hypoplasia. MalaCards

5. Developmental and neurologic screening — Simple bedside checks of tone, motor skills, and early milestones flag the need for therapy and further assessments. MalaCards

B) Manual/bedside tests

6. Newborn feeding and suck-swallow evaluation — Identifies cleft-related feeding difficulty and guides early support. Orpha

7. Hearing screening (otoacoustic emissions) — Quick, noninvasive test soon after birth to catch hearing issues that often accompany cleft palate. Orpha

8. Speech-language evaluation — Measures resonance, articulation, and language development; vital in children with cleft palate. Orpha

9. Vision screening — Basic acuity and eye alignment tests; eye anomalies are part of the syndrome spectrum. MalaCards

10. Orthopedic functional assessment — Gait observation and joint-range checks help plan braces, therapy, or surgery for foot and limb differences. MalaCards

C) Laboratory and pathological tests

11. Genetic testing: targeted analysis of NBAS — If the clinical picture fits AFFND1, sequencing NBAS can confirm the cause in some families. PubMed

12. Genetic testing: PIGB sequencing/splice analysis — In families negative for NBAS, testing PIGB (including intronic regions affecting splicing) can detect the GPI-anchor form. PubMed

13. Exome or genome sequencing — Broader testing is useful because the condition is extremely rare and genetically heterogeneous; it can find novel or unexpected variants. PubMed

14. Functional assays for GPI-anchor deficiency — Research/advanced labs may test cell-surface markers to show reduced GPI-anchored proteins in PIGB-related cases. PubMed

15. General labs guided by phenotype — For example, basic metabolic panel and liver enzymes if NBAS variants raise concern for overlapping NBAS-related problems; tests are tailored to the child. PMC

D) Electrodiagnostic tests

16. Electroencephalogram (EEG) — Used if seizures or unusual spells occur, particularly in GPI-anchor disorders where epilepsy can be part of the picture. PubMed

17. Brainstem auditory evoked responses (BAER) — Objective hearing test when behavioral audiology is hard to perform in infants or in children with developmental delay. (Standard in craniofacial/cleft care.) Orpha

E) Imaging tests

18. Skeletal survey / focused limb X-rays — Confirms extra/fused digits, short/bent bones, and checks for fibular hypoplasia or other structural differences. MalaCards

19. Craniofacial CT (low-dose or cone-beam when appropriate) — Helps surgeons plan cleft and jaw procedures and visualize nasal and midface structures. Orpha

20. Brain MRI (as indicated) — Looks for associated brain anomalies (part of the frontonasal dysplasia spectrum in some individuals) and helps evaluate development or seizures. PMC

Non-pharmacological treatments

(At least 15 items are physiotherapy, mind-body, “gene”/education-focused approaches as requested. Each item includes: Description (~100 words), Purpose, Mechanism, Benefits.)

These are supportive, evidence-informed strategies used across cleft/craniofacial and limb-difference care. Your own clinicians should personalize timing and intensity.

1. Early feeding support for cleft palate
   Description: A lactation/feeding specialist teaches positioning, pacing, and use of specialty cleft bottles/valves so milk reaches the throat without leaking into the nose. Caregivers learn upright feeding, frequent burping, and safe thickening if advised. A speech-language pathologist (SLP) follows growth, choking, nasal regurgitation, and weight gain. Written plans explain pump hygiene, formula preparation, and aspiration warning signs. Purpose: Ensure safe nutrition and growth before and after palate repair. Mechanism: Reduces negative nasopharyngeal pressure and compensates for palatal gap. Benefits: Better weight gain, fewer chest infections, calmer feeding, and caregiver confidence. Orpha

2. Cleft lip/palate team coordination (multidisciplinary clinic)
   Description: Regular visits with a coordinated team (plastic/craniofacial surgeon, ENT, SLP, orthodontist, audiologist, pediatrician, social worker). The team sets a timeline for palate repair, tube ears if needed, orthodontics, and speech therapy. Written care pathways reduce delays. Purpose: One-stop, staged care across childhood. Mechanism: Shared decision-making; synchronized surgeries/therapies. Benefits: Fewer missed steps; better feeding, speech, dentition, and psychosocial support. Orpha

3. Physiotherapy: infant gross-motor program
   Description: A pediatric PT trains caregivers in tummy time, supported sitting, rolling, and alignment. For lower-limb differences (e.g., fibular hypoplasia), PT focuses on hip/knee/ankle range, core strength, balance, and safe transitions (floor-to-stand). Home programs are short and frequent. Orthoses may be integrated after orthopedics evaluation. Purpose: Build strong, aligned movement patterns. Mechanism: Repetitive, task-specific practice shapes motor circuits; stretching preserves soft-tissue length. Benefits: Earlier milestones, fewer contractures, safer gait.

4. Physiotherapy: ankle–foot orthosis (AFO) training
   Description: If foot/ankle alignment is poor, a PT teaches donning/doffing AFOs, pressure-area checks, gait drills (step-through, stairs), and orthosis-compatible shoes. Purpose: Stabilize gait and protect joints. Mechanism: External support redistributes forces across weak/short segments. Benefits: Smoother walking, less fatigue, better participation.

5. Physiotherapy: hand function/constraint-induced practice
   Description: For a weaker hand, brief, supervised constraint of the stronger side encourages reaching, grasp, release, and bimanual tasks (stacking, dressing). Purpose: Improve functional use of the affected hand. Mechanism: Drives neuroplasticity through intensive, meaningful use. Benefits: Better independence in play/self-care.

6. Physiotherapy: serial casting for toe/foot deformity
   Description: Short casting cycles (weekly/biweekly) gently stretch tight soft tissues and improve foot position before bracing or surgery. Purpose: Correct progressive deformities early. Mechanism: Low-load, long-duration stretch remodels collagen. Benefits: More plantigrade foot, easier bracing, fewer skin problems.

7. Physiotherapy: gait and balance training
   Description: Obstacle courses, step-ups, tandem walking, and dynamic balance drills matched to orthopedic status. Purpose: Prevent falls; improve endurance. Mechanism: Repetitive sensorimotor training refines vestibular/proprioceptive control. Benefits: Safer mobility, confidence, participation.

8. Physiotherapy: respiratory physiotherapy (when needed)
   Description: For children with recurrent chest infections (e.g., due to aspiration), a PT teaches airway clearance, huff coughing, and postural drainage under clinician guidance. Purpose: Keep lungs clear. Mechanism: Mobilizes secretions and improves ventilation. Benefits: Fewer infections, better activity tolerance.

9. Occupational therapy (OT) for daily skills
   Description: OT adapts utensils, cups, toothbrushes; teaches dressing with limb differences; introduces environmental modifications (grips, Velcro, elastic laces). Purpose: Maximize independence. Mechanism: Task-specific practice plus assistive technology. Benefits: Faster self-care, improved self-esteem.

10. Speech-language therapy (pre- and post-palate repair)
    Description: SLP addresses velopharyngeal function, resonance, articulation, and compensatory patterns; uses visual feedback and home drills; liaises with ENT and orthodontics. Purpose: Clear speech and safe swallow. Mechanism: Motor learning with targeted cueing and resonance control. Benefits: Intelligibility, social inclusion, school success. Orpha

11. Hearing monitoring and early amplification (ENT/audiology)
    Description: Regular ear checks and tympanometry; prompt grommets (tubes) for effusions; hearing aids when indicated. Purpose: Protect language development. Mechanism: Restores auditory input during critical periods. Benefits: Better speech, learning, behavior.

12. Orthodontics and dentofacial orthopedics
    Description: Expansion devices, cross-bite correction, space maintenance, later braces; careful planning with craniofacial surgery timing. Purpose: Align teeth and jaws for function and aesthetics. Mechanism: Controlled forces guide growth and tooth movement. Benefits: Easier speech/chewing, hygiene, confidence.

13. Mind–body: family-centered coping and stress skills
    Description: Brief, structured sessions teach caregivers relaxation, paced breathing, and behavior activation to reduce medical-care stress. Purpose: Improve resilience. Mechanism: Lowers sympathetic arousal; supports adherence. Benefits: Better sleep, calmer clinic days, stronger teamwork.

14. Mind–body: age-appropriate child coping
    Description: Medical play, story-based preparation for surgery, and simple mindfulness for older children. Purpose: Reduce procedure anxiety and improve cooperation. Mechanism: Predictability reduces fear conditioning. Benefits: Smoother hospital experiences.

15. Education therapy and individualized education plan (IEP)
    Description: Neurodevelopmental assessment informs classroom supports (speech services, OT/PT in school, assistive tech, extra time). Purpose: Optimize learning. Mechanism: Removes access barriers; matches teaching to strengths. Benefits: Better grades, engagement, self-efficacy.

16. Parent skills training for home programs
    Description: Short, written and video-based guides for feeding, exercises, orthoses, and scar care; regular check-ins. Purpose: Make therapy doable. Mechanism: Repetition in real contexts. Benefits: Faster gains, fewer clinic visits.

17. Nutrition counseling
    Description: Dietitian designs calorie-dense, texture-modified meals; monitors iron, vitamin D, calcium, and protein intake. Purpose: Support growth and surgical healing. Mechanism: Adequate macro/micronutrients. Benefits: Weight gain, stronger immunity, better wound healing.

18. Scar and skin care education
    Description: Gentle massage, sun protection, silicone sheeting (if recommended), and infection warning signs after surgeries. Purpose: Improve scar quality. Mechanism: Pressure/hydration modulate collagen. Benefits: Softer, flatter scars, fewer complications.

19. Social work and care navigation
    Description: Links to travel aid, therapy funding, and peer support groups. Purpose: Reduce care burden. Mechanism: Practical problem-solving. Benefits: Less stress, better follow-through.

20. Orthotics & adaptive footwear
    Description: Custom shoes, inserts, or braces for foot/ankle alignment and limb-length issues. Purpose: Comfort and stability. Mechanism: Redistribute pressure; correct alignment. Benefits: Longer walking time, fewer sores.

21. Adaptive devices for fine-motor tasks
    Description: Built-up pens, page-turners, touch-screen stylus, switch access. Purpose: Participation in school and play. Mechanism: Device compensates for grip/hand shape. Benefits: Independence, inclusion.

22. Community-based physical activity
    Description: Swimming, cycling with adaptive pedals, seated sports. Purpose: Cardiometabolic health and socialization. Mechanism: Aerobic and strength training. Benefits: Fitness, mood, friendships.

23. Pre-surgical conditioning (“prehab”)
    Description: Light aerobic, breathing exercises, nutrition tune-up before planned surgery. Purpose: Better recovery. Mechanism: Improves reserve; lowers complications. Benefits: Shorter stays, quicker return to baseline.

24. Post-surgical rehabilitation pathway
    Description: Timetabled PT/OT/SLP after each surgery with milestones (e.g., diet advancement after palate repair). Purpose: Regain function safely. Mechanism: Progressive loading and practice. Benefits: Predictable recovery, fewer setbacks.

25. Genetic counseling
    Description: Reviews inheritance, recurrence risk, options for carrier testing and future pregnancy planning; clarifies gene findings (e.g., NBAS where relevant). Purpose: Informed family planning and support. Mechanism: Risk communication and testing pathways. Benefits: Clarity, reduced anxiety, earlier diagnosis for siblings. PubMed

---

Drug treatments

There is no disease-modifying medication for AFFND. Drugs below are commonly used to manage associated problems (pain, infection risk around surgeries, reflux, constipation, feeding intolerance, otitis media, etc.). Always individualize with your clinicians; pediatric dosing depends on age/weight and local protocols.

1. Acetaminophen (paracetamol) — Analgesic/antipyretic. Dose (typical): 10–15 mg/kg per dose every 4–6 h (max per local guideline). Time: Short courses peri-procedurally. Purpose: Reduce pain/fever after procedures. Mechanism: Central COX inhibition. Side effects: Rare liver toxicity with overdose.

2. Ibuprofen — NSAID analgesic/anti-inflammatory. Dose: ~5–10 mg/kg every 6–8 h with food (per guideline). Purpose: Post-op pain and inflammation (if surgeon approves). Mechanism: COX-1/COX-2 inhibition. Side effects: Gastric upset; avoid if bleeding risk/kidney issues.

3. Amoxicillin (or amoxicillin-clavulanate) — Antibiotic. Dose: per infection and local resistance (e.g., 40–90 mg/kg/day divided). Purpose: Otitis media/sinusitis linked to Eustachian tube dysfunction in cleft palate. Mechanism: Inhibits bacterial cell wall. Side effects: Diarrhea, rash.

4. Cefazolin (peri-operative) — First-gen cephalosporin IV. Dose: weight-based single dose per surgical prophylaxis guidelines. Purpose: Prevent surgical-site infection. Mechanism: Cell wall synthesis inhibition. Side effects: Allergy, GI upset.

5. Ondansetron — Antiemetic. Dose: weight-based oral/IV before/after anesthesia. Purpose: Prevent post-op nausea/vomiting. Mechanism: 5-HT3 receptor blockade. Side effects: Headache, constipation; rare QT prolongation.

6. Omeprazole (PPI) — Acid suppression. Dose: pediatric mg/kg/day per guideline. Purpose: Reflux that worsens feeding after palate repair. Mechanism: Blocks gastric proton pumps. Side effects: Headache; long-term use requires review.

7. Topical nasal saline — Supportive. Dose: sprays/drops as needed. Purpose: Moisturize nasal passages post-op; ease crusts. Mechanism: Mechanical irrigation. Side effects: Minimal.

8. Vitamin D3 (cholecalciferol) — Micronutrient. Dose: per age (often 400–1000 IU/day; tailor to labs). Purpose: Bone health in children with reduced weight-bearing. Mechanism: Improves calcium absorption. Side effects: Hypercalcemia if overdosed.

9. Elemental iron (ferrous sulfate) — Micronutrient. Dose: commonly ~3 mg/kg/day elemental iron (individualize). Purpose: Correct iron-deficiency from feeding difficulties. Mechanism: Builds hemoglobin. Side effects: Constipation, dark stools.

10. Polyethylene glycol (PEG 3350) — Osmotic laxative. Dose: individualized grams/day. Purpose: Constipation from low intake/opioids. Mechanism: Water retention in stool. Side effects: Bloating.

11. Melatonin — Sleep aid. Dose: child-specific low mg dose at bedtime. Purpose: Hospital/surgery-related sleep disruption. Mechanism: Circadian modulation. Side effects: Morning grogginess.

12. Topical antibiotic ointment (per surgeon) — Local wound care. Dose: thin layer to incision as instructed. Purpose: Reduce superficial infection risk. Mechanism: Local bacterial growth suppression. Side effects: Contact dermatitis.

13. Acetaminophen-codeine alternatives (e.g., low-dose morphine if required) — Analgesic. Dose: strictly weight-based and time-limited; avoid codeine in children. Purpose: Breakthrough post-op pain if non-opioids insufficient. Mechanism: μ-opioid receptor agonism. Side effects: Constipation, sedation; careful monitoring.

14. Intranasal corticosteroids (e.g., budesonide; if ENT advises) — Anti-inflammatory. Dose: per age. Purpose: Nasal inflammation affecting breathing/sleep after repairs. Mechanism: Local cytokine down-regulation. Side effects: Nasal dryness, minor epistaxis.

15. Probiotics (clinical-grade, if dietitian approves) — Gut support. Dose: per product. Purpose: Diarrhea after antibiotics. Mechanism: Microbiome modulation. Side effects: Gas; avoid in severe immunodeficiency.

(Because we used web sources, note again: there’s no medicine that cures AFFND; management is supportive and surgical. The drug list above reflects common peri-operative/associated-symptom care rather than disease-specific therapy.) Orpha

---

Dietary “molecular” supplements

Always check with your clinician; labs and age determine safe dosing.

1. Vitamin D3: 400–1000 IU/day typical (individualize). Function: bone mineralization. Mechanism: boosts calcium/phosphate absorption.

2. Calcium (diet first; supplement if needed): pediatric RDA-based. Function: bone strength. Mechanism: mineral substrate for bone.

3. Elemental Iron: ~3 mg/kg/day (per labs). Function: correct anemia. Mechanism: hemoglobin synthesis.

4. Omega-3 (DHA/EPA): age-appropriate mg/day. Function: neurodevelopment, anti-inflammatory. Mechanism: membrane and eicosanoid effects.

5. Zinc: 5–10 mg/day (dietitian to confirm). Function: wound healing, immunity. Mechanism: cofactor in DNA/protein synthesis.

6. Vitamin C: diet-focused; supplement if low intake. Function: collagen cross-linking. Mechanism: cofactor for prolyl/lysyl hydroxylase.

7. Protein/calorie modulars (e.g., whey, oral nutrition drinks): per dietitian. Function: growth and surgical recovery. Mechanism: nitrogen/energy repletion.

8. B12/Folate: only if deficient. Function: red cell and nerve health. Mechanism: one-carbon metabolism.

9. Magnesium: as advised. Function: muscle/nerve function; constipation aid (some forms). Mechanism: enzymatic cofactor/osmotic effect.

10. Probiotics: product-specific CFUs. Function: reduce antibiotic-associated diarrhea. Mechanism: microbiome support.

---

Regenerative / stem-cell drugs

At this time there are no approved stem-cell or “regenerative drug” therapies for AFFND. The U.S. FDA repeatedly warns that many stem-cell products marketed directly to patients are unapproved and potentially dangerous (infections, blindness, serious harm). If a clinical trial is being considered, families should verify oversight and approval status with regulators. For immune health, rely on vaccinations, nutrition, sleep, and infection prevention—not unproven injections. U.S. Food and Drug Administration+1

---

Surgeries

1. Cleft lip repair (cheiloplasty)
   Procedure: Precise rearrangement of lip tissues to close the cleft and restore muscle continuity. Why: Improve feeding, speech articulation support, oral competence, and appearance. Orpha

2. Cleft palate repair (palatoplasty)
   Procedure: Reconstruction of the soft and/or hard palate with muscle repositioning to restore velopharyngeal closure. Why: Enable normal speech resonance and reduce nasal regurgitation; supports Eustachian tube function. Orpha

3. Ear tubes (tympanostomy) by ENT
   Procedure: Small tubes placed in the eardrum to ventilate the middle ear. Why: Reduce effusions/otitis media to protect hearing and speech development.

4. Hand/foot reconstruction (syndactyly release, extra digit removal, foot realignment)
   Procedure: Staged orthopedic/hand surgery tailored to specific anomalies; may combine with tendon balancing and osteotomies. Why: Improve function, shoe wear, and gait.

5. Lower-limb procedures for fibular hypoplasia
   Procedure: Guided growth, osteotomies, limb-lengthening or ankle stabilization based on deformity severity. Why: Achieve plantigrade, stable foot and functional limb length.

(AFFND surgical principles borrow from broader cleft/craniofacial and limb-difference standards; plans are individualized by craniofacial and orthopedic teams.) Orpha

---

Prevention

1. Genetic counseling before future pregnancies; discuss autosomal-recessive risks. PubMed

2. Carrier testing where a family variant is known.

3. Prenatal/early ultrasound in at-risk pregnancies (cleft/limb checks).

4. Avoid tobacco/alcohol in pregnancy; follow folate and general prenatal nutrition.

5. Vaccinations on schedule to reduce respiratory infections that complicate feeding/recovery.

6. Early feeding plans for suspected cleft palate.

7. Early hearing checks to protect speech and language.

8. Fall-prevention at home (safe footwear, clutter-free paths) once walking begins.

9. Regular dental care (fluoride, hygiene) to protect repaired palate and alignment.

10. Healthy sleep, activity, and diet to support growth and immunity.

---

When to see a doctor urgently vs routinely

• Urgent: choking spells, repeated cyanosis, breathing pauses, severe feeding failure/weight loss, fever with ear pain or chest signs, surgical-site redness with pus/fever, sudden worsening of foot/ankle pain or loss of function.

• Soon (non-urgent): persistent nasal regurgitation, unclear speech after the expected therapy window, new hearing concerns, ill-fitting orthoses, school learning concerns, chronic constipation despite diet changes.

• Routine: growth checks, dental/orthodontic visits, therapy reviews, immunizations, vision/hearing screening.

---

What to eat and what to avoid

• Eat more: soft, nutrient-dense foods (eggs, yogurt, dal, soft fish, minced meats, mashed fruit/veg), healthy fats (ground nuts/seeds as pastes if safe), iron-rich items (lentils, meats, leafy greens with vitamin C), calcium sources (milk/curd/cheese or fortified alternatives), and protein-rich snacks.

• If swallowing is tricky: use texture-modified, moist foods; add gravies/sauces; choose specialty feeding bottles if advised.

• Hydrate well with water and, if needed, oral rehydration when ill.

• Limit/avoid: choking-risk hard foods (whole nuts, hard candies), highly sugary drinks (dental risk), and very spicy/acidic items if reflux is active.

• Supplements only as your team recommends—based on labs and growth.

---

Frequently Asked Questions

1. Is Richieri-Costa–Colletto the same as AFFND? Yes—most modern sources use that name as a synonym for Acro-fronto-facio-nasal dysostosis. Orphadisease-ontology.org

2. How rare is it? Extremely rare; Orphanet lists prevalence <1 per 1,000,000. Orpha

3. How is it inherited? Usually autosomal recessive (two copies of a variant). Orpha

4. Which gene is involved? Some families (AFFND1) show NBAS variants; evidence remains limited due to rarity. PubMed

5. Is there a cure? No single cure; care focuses on surgeries and supportive therapies. Orpha

6. Is this the same as Richieri-Costa–Pereira syndrome? No; RCPS is a different disorder linked to EIF4A3 repeat expansion, with a mandibular midline cleft. OrphaScienceDirect

7. What specialists are needed? Craniofacial surgeon, ENT, SLP, orthodontics, audiology, orthopedics, genetics, PT/OT, dietetics, pediatrics. Orpha

8. When is cleft repair done? Timing varies by center; teams schedule lip and palate repairs in staged fashion during infancy/early childhood. Orpha

9. Will my child walk normally? Many children walk with therapy, orthoses, and—if needed—orthopedic surgery; plans are individualized.

10. Can learning be supported? Yes—early hearing/speech care and school IEPs help.

11. What about pain? Short courses of acetaminophen/ibuprofen are common after procedures (if surgeon approves).

12. Are stem-cell treatments available? No approved stem-cell therapies for this condition; beware clinics selling unproven products. U.S. Food and Drug Administration+1

13. Is genetic testing useful? Yes—helps confirm diagnosis, clarify recurrence risk, and guide family planning; may explore NBAS where indicated. PubMed

14. Can braces help? Orthodontic care is often part of the plan for bite and jaw alignment following cleft repair. Orpha

15. What is the long-term outlook? With coordinated care, many children achieve good feeding, speech, mobility, and school participation; lifelong follow-up is common.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 03, 2025.